Kalos Management, Inc. - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 64 filers reported holding CONATUS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
Kalos Management, Inc. ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$13,000
-18.8%
43,940
+5.9%
0.01%0.0%
Q4 2019$16,000
+14.3%
41,500
-12.6%
0.01%0.0%
Q3 2019$14,000
+16.7%
47,5000.0%0.01%
+20.0%
Q2 2019$12,000
-87.6%
47,500
-6.8%
0.01%
-89.4%
Q4 2018$97,000
-62.8%
50,940
+9.0%
0.05%
-66.4%
Q3 2018$261,000
+218.3%
46,750
+211.7%
0.14%
+278.4%
Q2 2018$82,000
-50.0%
15,000
-50.0%
0.04%
-22.9%
Q1 2018$164,00030,0000.05%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Kalos Management, Inc. 47,500$12,0000.01%
Virtu Financial LLC 94,842$25,0000.00%
ACADIAN ASSET MANAGEMENT LLC 467,425$121,0000.00%
REILLY FINANCIAL ADVISORS, LLC 22,011$6,0000.00%
A.R.T. Advisors, LLC 60,430$16,0000.00%
GOLDMAN SACHS GROUP INC 25,350$7,0000.00%
MORGAN STANLEY 1,019$00.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 24,900$6,0000.00%
WOLVERINE TRADING, LLC 30,900$8,0000.00%
WOLVERINE TRADING, LLC 26,779$7,0000.00%
View complete list of CONATUS PHARMACEUTICALS INC shareholders